Robert Paul Hasserjian
#144,386
Most Influential Person Now
Robert Paul Hasserjian's AcademicInfluence.com Rankings
Robert Paul Hasserjianphilosophy Degrees
Philosophy
#7701
World Rank
#10948
Historical Rank
Logic
#4738
World Rank
#6063
Historical Rank
Robert Paul Hasserjianbiology Degrees
Biology
#10393
World Rank
#13721
Historical Rank
Molecular Biology
#1506
World Rank
#1533
Historical Rank
Download Badge
Philosophy Biology
Robert Paul Hasserjian's Degrees
- Doctorate Medicine Harvard University
Why Is Robert Paul Hasserjian Influential?
(Suggest an Edit or Addition)Robert Paul Hasserjian's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. (2016) (6707)
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. (2015) (1351)
- Bone progenitor dysfunction induces myelodysplasia and secondary leukemia (2010) (1023)
- Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles (1996) (765)
- B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma (2010) (350)
- Lymphoma of the Ocular Adnexa: A Study of 353 Cases (2007) (291)
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data. (2022) (249)
- Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres (2007) (248)
- Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2019) (237)
- Differential regulation of myeloid leukemias by the bone marrow microenvironment (2012) (229)
- Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel. (2022) (218)
- Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor (1997) (206)
- Bone marrow niches in haematological malignancies (2020) (199)
- Oncogenic Forms of NOTCH1 Lacking Either the Primary Binding Site for RBP-Jκ or Nuclear Localization Sequences Retain the Ability to Associate with RBP-Jκ and Activate Transcription* (1997) (195)
- Quantitation of Bacteria in Bone Marrow from Patients with Typhoid Fever: Relationship between Counts and Clinical Features (2001) (195)
- Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. (2009) (177)
- Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. (2014) (169)
- Thyroid Hormones Regulate Hypertrophic Chondrocyte Differentiation and Expression of Parathyroid Hormone‐Related Peptide and Its Receptor During Endochondral Bone Formation (2000) (159)
- Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. (2007) (155)
- Clinicopathologic analysis of follicular lymphoma occurring in children. (2002) (147)
- On-chip recapitulation of clinical bone-marrow toxicities and patient-specific pathophysiology (2019) (141)
- Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. (2013) (133)
- Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas (2007) (130)
- Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia (2011) (128)
- α-CTLA-4 mAb-associated Panenteritis: A Histologic and Immunohistochemical Analysis (2008) (124)
- Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. (2012) (123)
- Rethinking Ormond’s Disease (2013) (120)
- NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. (2007) (120)
- Rethinking Ormond’s Disease: “Idiopathic” Retroperitoneal Fibrosis in the Era of IgG4-Related Disease (2013) (118)
- Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. (2016) (110)
- Low Histologic Grade Follicular Lymphoma With High Proliferation Index: Morphologic and Clinical Features (2005) (108)
- Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch. (1994) (106)
- Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. (2010) (99)
- TEL/PDGFβR Induces Hematologic Malignancies in Mice That Respond to a Specific Tyrosine Kinase Inhibitor (1999) (99)
- Modulated expression of notch1 during thymocyte development. (1996) (91)
- Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis (2011) (87)
- Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification (2011) (87)
- Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified (2016) (87)
- Modulated expression of notch1 during thymocyte development (1996) (82)
- Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. (2017) (80)
- A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. (2006) (80)
- Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. (1998) (80)
- Carcinoma of the thymus with clear-cell features. Report of eight cases and review of the literature. (1995) (79)
- Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features (2006) (77)
- Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. (2012) (76)
- The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology. (1998) (73)
- Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol (2006) (72)
- High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen. (1999) (71)
- ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response. (2002) (71)
- Immunomodulator agent-related lymphoproliferative disorders (2009) (71)
- Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? (2004) (70)
- Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology (2010) (67)
- Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma (2009) (67)
- Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features (2012) (67)
- Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature (2005) (66)
- High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML. (2018) (63)
- Primary Follicular Lymphoma of the Gastrointestinal Tract (2011) (62)
- EBV May Be Expressed in the LP Cells of Nodular Lymphocyte–predominant Hodgkin Lymphoma (NLPHL) in Both Children and Adults (2014) (62)
- Diffuse large B-cell lymphomas and burkitt lymphoma. (2009) (60)
- Human cytotoxic T lymphocytes specific for Wilms’ tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients (2003) (59)
- Acute myeloid leukemia: advances in diagnosis and classification (2013) (58)
- Co-occurrence of Langerhans cell histiocytosis and Rosai–Dorfman disease: possible relationship of two histiocytic disorders in rare cases (2010) (58)
- THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision to the World Health Organization classi fi cation of myeloid neoplasms and acute leukemia (2016) (56)
- Primary Follicular Lymphoma of the Testis and Epididymis in Adults (2007) (55)
- Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation (2007) (54)
- Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study (2014) (53)
- Clonal Hematopoiesis and Measurable Residual Disease Assessment in Acute Myeloid Leukemia. (2020) (51)
- Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8. (2013) (50)
- Diagnostic Yield of CT-Guided Percutaneous Transthoracic Needle Biopsy for Diagnosis of Anterior Mediastinal Masses. (2015) (49)
- Expression of CD30 in patients with acute graft-versus-host disease. (2012) (48)
- Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification (2008) (47)
- Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems. (2014) (47)
- Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome (2017) (45)
- PRM-151 in Myelofibrosis: Efficacy and Safety in an Open Label Extension Study (2018) (45)
- Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia (2014) (44)
- Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia (2017) (44)
- Commentary on the WHO classification of tumors of lymphoid tissues (2008): indolent B cell lymphomas (2009) (44)
- Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities. (2015) (43)
- Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal (2021) (42)
- Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. (2006) (41)
- The immunophenotypic spectrum of primary mediastinal large B‐cell lymphoma reveals prognostic biomarkers associated with outcome (2016) (41)
- Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas (2009) (40)
- FLT3 inhibitor-induced neutrophilic dermatosis. (2013) (39)
- TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML (2022) (39)
- Pathology of thymic tumors. (2005) (39)
- Immunophenotypic Changes and Clinical Outcome in B-Cell Lymphomas Treated with Rituximab (2006) (38)
- Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia (2013) (38)
- Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results (2014) (37)
- PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks (2015) (37)
- High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome (2015) (37)
- Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study (2018) (36)
- tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish (2018) (35)
- Lymphomatoid Granulomatosis: CT and FDG-PET Findings (2011) (35)
- Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease. (1999) (35)
- Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6 (2001) (34)
- Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. (2015) (34)
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma With Atypical T Cells: A Morphologic Variant Mimicking Peripheral T-Cell Lymphoma (2011) (34)
- Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis (2015) (33)
- A distinct immunophenotype identifies a subset of NPM1‐mutated AML with TET2 or IDH1/2 mutations and improved outcome (2018) (33)
- Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma (2008) (33)
- European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia (2017) (33)
- TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. (1999) (31)
- Reclassifying myelodysplastic syndromes: what's where in the new WHO and why. (2015) (31)
- Myelodysplastic Syndrome Updated (2018) (31)
- A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma. (1998) (30)
- Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms. (2019) (28)
- Bone marrow findings correlate with clinical outcome in systemic AL amyloidosis patients (2007) (27)
- Primary lymphoma of bone in the pediatric and young adult population. (2017) (27)
- Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia (2015) (27)
- S828 A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM-151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB (2019) (26)
- Bone Marrow Reticulin in Patients with Immune Thrombocytopenic Purpura. (2006) (26)
- Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis (2009) (26)
- Aleukemic cutaneous myeloid sarcoma (2013) (26)
- De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study (2014) (25)
- Isolation and Functional Analysis of a cDNA for Human Jagged 2 , a Gene Encoding a Ligand for the Notch 1 Receptor (1997) (24)
- Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. (2019) (23)
- Erythroid proliferations in myeloid neoplasms. (2012) (22)
- Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms. (2016) (22)
- Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura (2009) (22)
- JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group (2018) (21)
- Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts (2016) (21)
- Molecular testing for JAK2, MPL, and CALR in myeloproliferative neoplasms (2016) (21)
- Inter-reader variability in follicular lymphoma grading: Conventional and digital reading (2013) (21)
- Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells (2020) (21)
- Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study (2020) (20)
- High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms (2014) (20)
- Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia (2020) (20)
- Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation. (2000) (19)
- A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance) (2013) (19)
- TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes (2019) (18)
- Small‐cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population (2016) (18)
- Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features. (2011) (18)
- High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia (2019) (18)
- Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures (2019) (17)
- Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T‐cell expansion (2007) (16)
- Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia. (2022) (16)
- Case records of the Massachusetts General Hospital. Case 11-2007. A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies. (2007) (16)
- JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology (2021) (16)
- Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma (2021) (16)
- The current approach to the diagnosis of myelodysplastic syndromes☆. (2019) (16)
- Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group (2019) (16)
- Twin Girls with Neurocutaneous Symptoms Caused by Mothball Intoxication (2006) (16)
- Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system (2005) (16)
- Case records of the Massachusetts General Hospital. Case 8-2006. A 71-year-old woman with Crohn's disease and altered mental status. (2006) (15)
- Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities (2018) (15)
- Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome (2018) (15)
- Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis (2017) (15)
- Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma. (2020) (15)
- Reactive versus neoplastic bone marrow: problems and pitfalls. (2008) (15)
- Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome. (2019) (15)
- Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasms. (2015) (14)
- CD30 expression in acute myeloid leukemia is associated with FLT3-internal tandem duplication mutation and leukocytosis (2013) (14)
- Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study (2020) (13)
- Recurrences in nodal T-cell lymphoma. Changes in histologic appearance and immunophenotype over the course of disease. (2000) (13)
- A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia (2019) (13)
- The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading (2014) (13)
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-2004. A 12-year-old boy with fatigue and eosinophilia. (2004) (13)
- Case records of the Massachusetts General Hospital. Case 9-2011. A 37-year-old man with flushing and hypotension. (2011) (13)
- Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. (2016) (12)
- Castleman disease presenting in the neck: report of a case and review of the literature. (2013) (12)
- Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2020) (12)
- Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma (2011) (12)
- Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions (2020) (12)
- Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach (2022) (12)
- JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms (2017) (12)
- Evidence of Long Latency Periods Prior to Development of Mantle Cell Lymphoma (2010) (12)
- Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells (2011) (11)
- Contribution of Clonal Hematopoiesis to Adult-Onset Hemophagocytic Lymphohistiocytosis. (2020) (11)
- Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to bone (2013) (11)
- NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification (2017) (11)
- Pure erythroid leukemia evolving from a therapy‐related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia (2013) (11)
- Prior cytopenia predicts worse clinical outcome in acute myeloid leukemia. (2015) (10)
- Case records of the Massachusetts General Hospital. Case 8-2008. A 33-year-old man with fever, abdominal pain, and pancytopenia after renal transplantation. (2008) (10)
- The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13. (2021) (10)
- Deletion of chromosome 20q: friend or foe? (2011) (10)
- Nuclear IHC enumeration: A digital phantom to evaluate the performance of automated algorithms in digital pathology (2018) (10)
- Case records of the Massachusetts General Hospital. Case 17-2006--a 34-year-old man with cavitary lung lesions. (2006) (9)
- Diagnostic utility of cerebrospinal fluid flow cytometry in patients with and without prior hematologic malignancy (2014) (9)
- Extranodal natural killer T-cell lymphoma, nasal type, with minimal osseous involvement: report of a case and literature review. (2010) (9)
- Diagnosis of Burkitt Lymphoma and Related High-Grade B-Cell Neoplasms. (2010) (9)
- Human bone marrow disorders recapitulated in vitro using organ chip technology (2018) (9)
- Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era? (2015) (9)
- How I Diagnose Low-Grade Myelodysplastic Syndromes. (2020) (9)
- Myeloid/lymphoid neoplasms with FLT3 rearrangement (2021) (9)
- Guiding the global evolution of cytogenetic testing for hematologic malignancies (2022) (9)
- Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1 (2020) (8)
- Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis (2020) (8)
- Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle? (2015) (8)
- Erythroleukemia and Its Differential Diagnosis. (2013) (8)
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 15-2004. A 31-year-old man with bilateral testicular enlargement. (2004) (8)
- Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome (2017) (8)
- Composite chronic myeloid leukemia and essential thrombocythemia with BCR‐ABL1 fusion and CALR mutation (2018) (8)
- Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression (2020) (7)
- Lymphadenitis (2019) (7)
- Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response (2016) (7)
- Case records of the Massachusetts General Hospital. Case 16-2007. A 61-year-old man with a mediastinal mass. (2007) (7)
- Diagnostic algorithm for lower-risk myelodysplastic syndromes (2018) (7)
- Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study (2017) (7)
- Effect Of Treatment With The JAK2-Selective Inhibitor Fedratinib (SAR302503) On Bone Marrow Histology In Patients With Myeloproliferative Neoplasms With Myelofibrosis (2013) (7)
- Case records of the Massachusetts General Hospital. Case 7-2014. A 27-year-old man with diarrhea, fatigue, and eosinophilia. (2014) (7)
- Case records of the Massachusetts General Hospital. Case 1-2012. An 82-year-old man with persistent ulcers on the hands. (2012) (7)
- Computer‐assisted quantification of CD3+ T cells in follicular lymphoma (2017) (6)
- Diffuse Cellular and Fibrosing Interstitial Pneumonitis With Desquamative Interstitial Pneumonitis-like Features Associated With Myeloid Neoplasia (2009) (6)
- Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms. (2020) (6)
- Case records of the Massachusetts General Hospital. Case 30-2006. A 41-year-old man with dyspnea, fever, and lymphadenopathy. (2006) (6)
- Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment (2020) (6)
- FOXP3-stained image analysis for follicular lymphoma: optimal adaptive thresholding with maximal nucleus coverage (2017) (6)
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-2005. A 39-year-old woman with headache, stiff neck, and photophobia. (2005) (6)
- Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia. (2021) (6)
- Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category (2016) (6)
- Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias). (2019) (5)
- Segmentation of follicles from CD8-stained slides of follicular lymphoma using deep learning (2019) (5)
- Updates on eosinophilic disorders (2022) (5)
- Advances in myelodysplastic/myeloproliferative neoplasms (2022) (5)
- A Directly Spliced Exon 10–Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma (1998) (5)
- Evaluation of Bone Marrow Reticulin Formation in Romiplostim-Treated Adult Patients with Chronic Immune Thrombocytopenic Purpura (ITP). (2008) (5)
- The International Consensus Classification of acute myeloid leukemia (2022) (5)
- Case records of the Massachusetts General Hospital. Case 35-2008. A 65-year-old man with confusion and memory loss. (2008) (5)
- Induces Hematologic Malignancies in Mice That Respond to a Specific Tyrosine Kinase Inhibitor (1999) (4)
- Case records of the Massachusetts General Hospital. Case 36-2010. A 50-year-old woman with pain and loss of hearing in the left ear. (2010) (4)
- A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria (2018) (4)
- CT-guided bone marrow aspirations and biopsies: retrospective study and comparison with blind procedures (2020) (4)
- Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Reduces Leukemic Stem Cells in Murine Chronic Myelogenous-Leukemia-Like Disease Via a TGFbeta-Dependent Pathway (2011) (4)
- Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology (2020) (4)
- Case records of the Massachusetts General Hospital. Case 13-2006. A 50-year-old man with a painful bone mass and lesions in the liver. (2006) (4)
- Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML. (2021) (4)
- Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Monoclonal B-Cell Lymphocytosis. (2010) (4)
- Premalignant Clonal Hematopoietic Proliferations. (2019) (4)
- Berardinelli-Seip lipodystrophy (2007) (4)
- Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes (2022) (4)
- Combined Targeted Therapy for BRAF-Mutant, Treatment-Related Acute Myeloid Leukemia. (2017) (4)
- Pharmacokinetics of an oral VEGF receptor tyrosine kinase inhibitor (PTK787/ZK222584) in patients with myelodysplastic syndrome (MDS): Cancer and Leukemia Group B Study 10105. (2006) (4)
- Philadelphia Chromosome Positive Acute Myeloid Leukemia: An Aggressive Acute Leukemia with Clinicopathologic Features Distinct from Chronic Myeloid Leukemia in Blast Crisis. (2005) (4)
- Secondary‐type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1 (2022) (4)
- Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with p-Lyn and p-Syk (2010) (4)
- Myelodysplastic/ Myeloproliferative Neoplasms-Unclassifiable (MDS/MPN-U) with Isolated Isochromosome 17q Represents a Distinct Clinico-Biologic Subset: A Multi-institutional Collaborative Study from the Bone Marrow Pathology Group (2021) (4)
- An agenda to advance research in MDS: A TOP 10 Priority List from the first international workshop in MDS (iwMDS). (2022) (3)
- TP53‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity (2022) (3)
- Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression. (2017) (3)
- Pathology quiz case 2. Myeloid sarcoma (MS) of the submandibular gland. (2011) (3)
- Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group (2021) (3)
- Case records of the Massachusetts General Hospital. Case 33-2007. A 49-year-old HIV-positive man with anemia. (2007) (3)
- mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome (2022) (3)
- Illuminating neutrophilic myeloid neoplasms. (2019) (3)
- Case 11-2007 : A 59-Year-Old Man with Neck Pain , Weakness in the Arms , and Cranial-Nerve Palsies (2007) (3)
- Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information (2015) (3)
- The International Consensus Classification of myelodysplastic syndromes and related entities (2022) (3)
- Identification of germline variants in adults with hemophagocytic lymphohistiocytosis. (2020) (3)
- Response to “The WHO classification of haematolymphoid tumours” (Editorial) (2022) (3)
- Emerging patterns in clonal haematopoiesis (2019) (3)
- Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes. (2023) (3)
- Diagnosis of Blood and Bone Marrow Disorders (2018) (3)
- Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma. (2021) (3)
- Immunophenotyping in the differential diagnosis of histologically low grade B cell lymphomas (2000) (3)
- Prognostic Significance of Residual Acute Myeloid Leukemia in Bone Marrow Samples Taken Prior to Allogeneic Hematopoietic Cell Transplantation (2017) (3)
- Case 9-2011 (2011) (3)
- Tumor microenvironment for follicular lymphoma: structural analysis for outcome prediction (2018) (2)
- Marginal zone B‐cell lymphoma of the infratemporal fossa: A rare case and review (2010) (2)
- A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML. (2021) (2)
- Acute myeloid leukemia in a patient with constitutional 47,XXY karyotype (2015) (2)
- Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group (2018) (2)
- Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group (2018) (2)
- Lymph node FNA cytology: Diagnostic performance and clinical implications of proposed diagnostic categories (2021) (2)
- Characterization of applicants for residency training in pathology: Does diversity exist? (2019) (2)
- Marginal zone B‐cell lymphoma of the head and neck: a rare case and review (2010) (2)
- Morphological, Flow Cytometry, and Cytogenetic Diagnosis of MDS (2020) (2)
- A Phase II Study of an Oral VEGF Receptor Tyrosine Kinase Inhibitor (PTK787/ZK222584) in Patients with Myelodysplastic Syndrome (MDS): Cancer and Leukemia Group B Study 10105. (2006) (2)
- Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable (2012) (2)
- Global Cytopathology-Hematopathology Practice Trends. (2021) (2)
- Comprehensive Genomic Profiling of 104 Rare Histiocytic and Dendritic Cell Neoplasms Reveals Shared and Distinct Targetable Genomic Alterations (2019) (2)
- Myelodysplastic syndromes with no somatic mutations detected by next‐generation sequencing display similar features to myelodysplastic syndromes with detectable mutations (2021) (2)
- Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2021) (2)
- Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia (2022) (2)
- Advances in the diagnosis and classification of myelodysplastic syndromes (2015) (2)
- TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes (2021) (2)
- Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2021) (1)
- Clinicopathologic Characterization of Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Reveals That Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival; A Bone Marrow Pathology Group Study (2012) (1)
- Ocular adnexal lymphoma: long-term outcome, patterns of failure and prognostic factors in 174 patients (2020) (1)
- Chronic myelogenous leukemia in the age of imatinib: assessing response, acceleration, and blast phase (2011) (1)
- Hairy Cell Leukemia (2011) (1)
- Leukocytosis: Neutrophilia, Basophilia, and Blasts (2018) (1)
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-2004. A 58-year-old man with acute myeloid leukemia and Fever after chemotherapy. (2004) (1)
- Oligoblastic (<20%) Myeloid Neoplasms with KMT2A (MLL) Rearrangement Show Significant Overlap with Acute Myeloid Leukemia (AML) and Should be Regarded As AML (2021) (1)
- Whole Genome Sequencing Provides Efficient and Comprehensive Genetic Risk Stratification in Acute Myeloid Leukemia and Myelodysplastic Syndrome (2021) (1)
- Infectious Diseases of the Bone Marrow and Spleen (2018) (1)
- Cytopenias: Reactive and Neoplastic (2018) (1)
- Outcomes in Myelofibrosis Patients Completing 24 and 36 Weeks of Treatment with PRM-151 (2015) (1)
- Multiorgan failure in a fatal case of autoimmune hemolytic anemia (2021) (1)
- Molecular genetic testing in the diagnosis of myeloid neoplasms (2019) (1)
- Case records of the Massachusetts General Hospital. Case 27-2010. A 73-year-old woman with chronic anemia. (2010) (1)
- Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. (2023) (1)
- Niche Induced Myelodysplasia and Secondary Hematopoietic Neoplasia Caused by Deletion of Dicer1 in Osteoprogenitor Cells. (2009) (1)
- Case records of the Massachusetts General Hospital. Case 14-2006. A 25-year-old woman with anemia and iron overload. (2006) (1)
- Revealing the dark secrets of TP53-mutated AML. (2022) (1)
- Pediatric-Type Nodal Follicular Lymphoma in Children and Adults Is Nearly Genetically Silent and Biologically Distinct from Typical Follicular Lymphoma (2015) (1)
- A unique PML-RARα rearrangement involving chromosomes 11, 15, and 17 in a patient with acute promyelocytic leukemia. (2013) (1)
- Blood and Bone Marrow Pathology (2004) (1)
- Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network (2022) (1)
- Cytogenetic evolution between diagnosis and relapse and impact on acute myeloid leukemia (AML) reinduction outcomes. (2017) (1)
- Bedside to Bench and Back: Identifying a New Clinically Relevant Driver in Pediatric Acute Myeloid Leukemia. (2022) (1)
- Chronic Myelogenous Leukemia (2012) (1)
- Resistant T-Cell Acute Lymphoblastic Leukemias That Emerge after In Vivo Treatment with Dexamethasone Frequently Down-Regulate Glucocorticoid Receptor Protein Expression (2016) (1)
- Flow cytometry reveals the nuances of clonal haematopoiesis (2021) (1)
- Author response: tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish (2018) (1)
- Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly. (2016) (1)
- Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. (2023) (1)
- Follicular Hyperplasia (2019) (1)
- Detection of Dual IDH 1 and IDH 2 Mutations by Targeted Next-Generation Sequencing in Acute (2015) (1)
- Normal-Karyotype Acute Myeloid Leukemia (2014) (0)
- Massive hepatomegaly and involvement by Janus kinase 2–positive myeloproliferative neoplasm (2010) (0)
- Corrigendum to: Global Cytopathology-Hematopathology Practice Trends. (2021) (0)
- This Year’s Best in Hematology Diagnosis: Mapping the Heterogeneity of Chronic Lymphocytic Leukemia (2023) (0)
- Kidney/Renal Pathology (2016) (0)
- TP53 Immunostaining in Double-Hit and Double-Expressing High-Grade B-Cell Lymphoma (2016) (0)
- Cancer Therapy : Clinical Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia (2011) (0)
- Prognostic Impact of Secondary Versus De Novo Ontogeny in Acute Myeloid Leukemia (AML) Is Predominantly Accounted for By the European Leukemianet (ELN) 2022 Risk Classification (2022) (0)
- Bone marrow niches in haematological malignancies (2020) (0)
- Separating Innocuous “CHIP” Mutations From Ominous “CHOP” Mutations in Patients With Treated AML in Remission (2021) (0)
- B-Cell Lymphocytosis (2018) (0)
- Myelodysplastic Syndromes (2020) (0)
- Cat Scratch Lymphadenitis (2019) (0)
- International Consensus Classification for myeloid neoplasms at‐a‐glance (2022) (0)
- Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements (2023) (0)
- Survival of the Fittest: Hypomethylating Agent/BCL-2 Inhibitor Combination Versus Intensive Chemotherapy As Frontline Treatment for Acute Myeloid Leukemia (2022) (0)
- Pathology quiz case 1. Diffuse large B-cell lymphoma (DLBCL). (2010) (0)
- Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2021) (0)
- Case records of the Massachusetts General Hospital. Case 28-2009. A 68-year-old man with fatigue, cough, and peripheral-blood monocytosis. (2009) (0)
- On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology (2020) (0)
- TP 53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS / AML Tracking no : ADV-2021-006239 R 2 (2022) (0)
- Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive. (2022) (0)
- Philadelphia-positive mast cell differentiation of CD34+ chronic phase CML cells after long-term engraftment in NOD/SCID mice (1998) (0)
- Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors (2022) (0)
- An unusual lymphoma involving the GI tract and bone marrow (2022) (0)
- PEDIATRIC MYELODYSPLASTIC SYNDROME (2023) (0)
- In Response to Lymphohematopoietic Clones (2022) (0)
- Size Matters in Lymphoma Diagnosis Tissue Biopsy (2023) (0)
- Erythroid nuclear dysplasia is associated with inferior outcomes for patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation. (2021) (0)
- Topic: AS01-Diagnosis/AS01a-Cytomorphology: AUTOMATED DIGITAL TOOL FOR MDS AND MDS/MPN CLASSIFICATION USING WHO AND ICC: INTERNATIONAL GUIDELINES WORKING GROUP ON MDS DIAGNOSIS, PROGNOSIS, AND GERMLINE PREDISPOSITION (2023) (0)
- Granulocytic Sarcoma of the Submandibular Gland (2009) (0)
- Kenyan nodular lymphocyte predominant Hodgkin lymphoma shares features with western cases and is not associated with EBV (2014) (0)
- Chapter 12 – Infectious Diseases of the Bone Marrow and Spleen (2010) (0)
- Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto‐Heme Interinstitutional Collaborative study (2022) (0)
- Changes in ABC Transporter Expression during Hematopoiesis Cause Lineage-Biased Cytopenias in Patients Treated with Aurora Kinase Inhibitors (2021) (0)
- Follicular Dendritic Cell Sarcoma of Uterine Corpus: Report of 2 Cases. (2022) (0)
- NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. (2022) (0)
- Introduction. (2019) (0)
- Therapy-Related Erythroleukemia in a Man With Metastatic Ewing Sarcoma: A Clinical Role for Advanced Molecular Diagnostics. (2018) (0)
- Computer vision quantitation of erythrocyte shape abnormalities provides diagnostic, prognostic, and mechanistic insight. (2023) (0)
- Chapter 13 – Lymphomas of the Bone Marrow (2011) (0)
- A Machine-Learning Derived Red Blood Cell Morphology Tool Enables Differential Diagnosis and Novel Single-Cell Analyses (2022) (0)
- Kidney/Renal Pathology (2016) (0)
- Precursor B Lymphoblastic Lymphoma Restricted to the Central Nervous System: A Case Report (2007) (0)
- Moving toward more molecular classifications of myelodysplastic syndrome and acute myeloid leukemia (2022) (0)
- Comprar Current Concepts in Hematopathology: Applications in Clinical Practice, An Issue of Surgical Pathology Clinics | Robert Paul Hasserjian | 9781437724998 | Saunders (2010) (0)
- Preface: Diagnostic Hematopathology: Aiming at a Moving Target. (2010) (0)
- Kikuchi-Fujimoto Lymphadenitis (2019) (0)
- Pathology quiz case 1. Diffuse large B-cell lymphoma (DLBCL) of the thyroid. (2011) (0)
- Correlation of bone marrow findings with organ distribution and amyloid burden in 103 patients with AL amyloidosis. (2000) (0)
- TP53-mutated Acute Myeloid Leukemia and Myelodysplastic Syndrome With Excess Blasts: Two Sides of the Same Coin? (2022) (0)
- Severe Erythroid Dysplasia at the Time of Allogeneic Hematopoietic Cell Transplantation May Predict Worse Survival for Patients with Myelodysplastic Syndrome (2018) (0)
- Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS-Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109 (2016) (0)
- IPSS-M Incorporates Next-Generation Sequencing for a New International Prognostic Scoring System (2022) (0)
- Update on the WHO classification of myeloid neoplasms (2014) (0)
- Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia (2011) (0)
- Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Myeloid Leukemia (2018) (0)
- Sinus Histiocytosis (2019) (0)
- Molecular Pathology of Myelodysplastic/Myeloproliferative Neoplasms, Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, and FGFR1, and Mastocytosis (2010) (0)
- Diffuse L arge B - Cell Lymphomas a nd Burkitt Lymphoma (2009) (0)
- Precursor B lymphoblastic lymphoma restricted to the central nervous system: a case report: 555.14 (2007) (0)
- Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology (2020) (0)
- Dermatopathic Lymphadenitis (2019) (0)
- Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. (2023) (0)
- Bone Marrow Morphologic Findings in Patients Receiving IDH Inhibitor Therapy in Combination with Intensive Induction Chemotherapy: Challenges with Interpretation of the Day 14 Bone Marrow Biopsy (2019) (0)
- Diagnosis: Myeloid sarcoma (MS) of the submandibulargland (2011) (0)
- Abstract 6168: Implementation and adoption of a web tool to support precision diagnostic and treatment decisions for patient with myelodysplastic syndromes (2023) (0)
- Toxoplasma Lymphadenitis (2019) (0)
- High Grade Lymphoma Mimicking Advanced Nasopharyngeal Carcinoma (2009) (0)
- Granulomatous Lymphadenitis (2019) (0)
- Finding the True Hits in Double-Hit Lymphomas (2021) (0)
- 2008 WHO classification Acute erythroid leukemia: a reassessment using criteria refined in the (2013) (0)
- Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma (2022) (0)
- Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: ready for prime time? (2012) (0)
- Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know (2017) (0)
- The Seeds of Progression From Myelodysplastic Syndrome to Acute Myeloid Leukemia Are Sown Early in the Course of Disease (2022) (0)
- The World Health Organization (WHO) classification recognizes a group of myeloid neoplasms with overlapping features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (2014) (0)
- unclassifiable myelodysplastic/myeloproliferative neoplasms Atypical chronic myeloid leukemia is clinically distinct from (2014) (0)
- ALK-positive Histiocytosis: An Old Target Shows Up in a New Disguise (2022) (0)
- Diagnosis: Diffuse large B-cell lymphoma (DLBCL) (2010) (0)
- Introduction2017 Society for Hematopathology/European Association for Haematopathology Workshop Report (2019) (0)
- Incidence, Clinical Associations, and Co-Mutation Patterns of UBA1 Mutations in MDS (2022) (0)
- Challenges in bone marrow pathology (2014) (0)
- Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group (2021) (0)
- Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS). (2023) (0)
- Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis (2015) (0)
- Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms (2022) (0)
- Myelodysplastic syndrome Diagnostic algorithm for lower-risk myelodysplastic syndromes (2018) (0)
- Navigating Myelodysplastic and Myelodysplastic/Myeloproliferative Overlap Syndromes. (2021) (0)
- Case 33-2021: A 68-Year-Old Man with Painful Mouth Ulcers. (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert Paul Hasserjian?
Robert Paul Hasserjian is affiliated with the following schools:
